<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00417456</url>
  </required_header>
  <id_info>
    <org_study_id>2005-P-000289</org_study_id>
    <nct_id>NCT00417456</nct_id>
  </id_info>
  <brief_title>The Development and Evaluation of an &quot;E-Visit&quot; Program for the Management of Acne</brief_title>
  <official_title>The Development and Evaluation of an &quot;E-Visit&quot; Program for the Management of Acne</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an&#xD;
      online &quot;E-Visit&quot; application that uses store-and-forward technology for acne patients&#xD;
      requiring dermatologic care for their condition. Hypotheses:&#xD;
&#xD;
        1. That an &quot;E-Visit&quot; is an effective alternative to in-person clinic care for patients with&#xD;
           mild to severe facial acne.&#xD;
&#xD;
        2. That providers and patients will be satisfied with this model.&#xD;
&#xD;
        3. That mean wait times for new and return visits will be reduced through the &quot;E-Visit&quot;&#xD;
           model.&#xD;
&#xD;
        4. That this prototype for care will improve clinic workflow, offer additional patient&#xD;
           access, and allow urgent cases to be seen earlier.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Across the United States, a geographically mal-distributed workforce of Dermatologists&#xD;
      exists, a problem that is projected to worsen. Patient access to dermatologic care is&#xD;
      threatened. The dermatology workforce shortage has resulted in long wait times for patients,&#xD;
      especially new patient visits and acute care cases.&#xD;
&#xD;
      Teledermatology has received much attention as a solution to the preceding problems.&#xD;
      Teledermatology can reduce the burden of repeat office visits in chronic conditions by&#xD;
      facilitating care from home. In this trial, a model incorporating store-and-forward&#xD;
      technology is tested in general clinics while its impact on clinical outcomes, satisfaction,&#xD;
      and wait times are studied.&#xD;
&#xD;
      Comparison: After consent, study subjects are assigned a unique study number and randomly&#xD;
      assigned to one of two groups:&#xD;
&#xD;
      Group 1- The first group of subjects will have four (4) in-office visits spaced six weeks&#xD;
      apart.&#xD;
&#xD;
      Group 2- The second group will have four (4) &quot;e-visits&quot; spaced six weeks apart.&#xD;
&#xD;
      At the end of study (after completion of 5th visit overall) all participants will complete a&#xD;
      satisfaction survey.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peer review of subject images using the Total Inflammatory Lesion Count at the end of active recruitment</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject satisfaction</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician satisfaction</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timing of visits</measure>
    <time_frame>ongoing</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">151</enrollment>
  <condition>Acne Vulgaris</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Office Visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Evisit</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Evisit</intervention_name>
    <description>Asynchronous,remote care delivery via a secure web platform</description>
    <arm_group_label>2</arm_group_label>
    <other_name>RelayHealth platform</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Office visit</intervention_name>
    <description>Conventional office-based care</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 12 or older&#xD;
&#xD;
          -  Diagnosis of mild to severe facial acne&#xD;
&#xD;
          -  Access to a credit card&#xD;
&#xD;
          -  Access to an Internet connection and a computer&#xD;
&#xD;
          -  Ability to image self&#xD;
&#xD;
          -  MA Blue Cross/ Blue Shield Coverage&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-English speaking individuals&#xD;
&#xD;
          -  Patients taking Accutane for their acne&#xD;
&#xD;
          -  Impaired Physical ability to image self&#xD;
&#xD;
          -  Impaired Cognitive ability&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph C. Kvedar, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MGH Dermatology Associates</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital Department of Dermatology</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <study_first_submitted>December 29, 2006</study_first_submitted>
  <study_first_submitted_qc>December 29, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 1, 2007</study_first_posted>
  <last_update_submitted>March 14, 2012</last_update_submitted>
  <last_update_submitted_qc>March 14, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Joseph C. Kvedar</investigator_full_name>
    <investigator_title>Director, Center for Connected Health</investigator_title>
  </responsible_party>
  <keyword>Acne</keyword>
  <keyword>Telemedicine</keyword>
  <keyword>Dermatology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

